Analysis of COVID-19 vaccine type and adverse effects following complete vaccination
DOI:
https://doi.org/10.61529/idjp.v33i2.266Abstract
Backgrounds: Immunization is one of the most successful and cost-effective health interventions to prevent infectious diseases. The launch of the COVID-19 vaccine rollout in December 2020 was a landmark for overcoming this pandemic crisis. It is therefore very important to get most of the population vaccinated as definitive cure still does not exist and people must take all required doses on time as required to reach full immunity. To find the association between covid-19 vaccine type and adverse effects following complete vaccination.
Material and Methods: This Cross-sectional study was conducted in Sharif Medical and Dental College, Lahore over a period of one year from January 2022 to January 2023 on a total of 100 individuals. All participants irrespective of their age and gender were included in the study. Participants with any other systemic illness or those on medication for other illnesses were excluded from the study. Data was collected using a pre-validated questionnaire
Results: The association between the type of vaccine and post-vaccination symptom were significant for fever (p=0.018) and cough (p=0.015).
Conclusion: Fever and cough were most prevalent among individuals who received Sinovac. Most of the symptoms were more prevalent in Sinovac recipients as compared to Sinopharm. Post-vaccination COVID-19 infection was also more prevalent in those who received Sinovac.
Keywords: COVID-19 infection, COVID-19 vaccination, Side effects
References
Kim Y, Bae S, Chang HH, Kim SW. Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: Prospective cohort study. Sci Rep. 2024; 14(1): 854.
DOI: https://doi.org/10.1038/s41598-023-50024-4
Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020; 8(3): 482.
DOI: https://doi.org/10.3390/vaccines8030482
Le TT, Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020; 19(5): 305-6.
DOI: https://doi.org/10.1038/d41573-020-00073-5
Bick A, Blandin A, Mertens K. Work from home before and after the COVID-19 outbreak. AEJ: Macroeconomics. 2023; 15(4): 1-39.
Bennett BW, Phillips LS, Gazmararian JA. The Association of vaccination for common adult infectious diseases and uptake of COVID-19 vaccines among 5,006,851 veterans, 20 December 2020–31 October 2021. Vaccines. 2024; 12(2): 145. DOI: https://doi.org/10.3390/vaccines12020145
Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 vaccine booster: To boost or not to boost. Infect Dis Rep. 2021; 13(4): 924-9.
DOI: https://doi.org/10.3390/idr13040084
Alhazmi A, Alamer E, Daws D, Hakami M, Darraj M, Abdelwahab S, et al. Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia. Vaccines. 2021; 9(6): 674.
DOI: https://doi.org/10.3390/vaccines9060674
Abdollahi A, Naseh I, Kalroozi F, Kazemi-Galougahi MH, Nezamzadeh M, Billandi SS, et al. Comparison of side effects of COVID-19 vaccines: Sinopharm, astraZeneca, sputnik V, and covaxin in women in terms of menstruation disturbances, hirsutism, and metrorrhagia: a descriptive-analytical cross-sectional study. Int J Fertil Steril. 2022; 16(3): 237.
DOI: https://doi.org/10.22074/ijfs.2022.544706.1236
Mohebbi A, Eterafi M, Fouladi N, Golizadeh M, Panahizadeh R, Habibzadeh S, et al. Adverse effects reported and insights following Sinopharm COVID-19 vaccination. Curr Microbiol. 2023; 80(12): 377.
DOI: https://doi.org/10.1007/s00284-023-03432-8
Halim M, Halim A, Tjhin Y. COVID-19 vaccination efficacy and safety literature review. J Clin Med Res. 2021; 3(1): 1-0.
DOI: https://doi.org/10.4103%2Fijmr.IJMR_474_21
Zhao H, Li Y, Wang Z. Adverse event of Sinovac coronavirus vaccine: Deafness. Vaccine. 2022; 40(3): 521-3.
DOI: https://doi.org/10.1016/j.vaccine.2021.11.091
Khani E, Khiali S, Entezari‐Maleki T. Potential COVID‐19 therapeutic agents and vaccines: An evidence‐based review. J Clin Pharmacol. 2021; 61(4):429-60.
DOI: https://doi.org/10.1002/jcph.1822
Qureshi A, Sulaiman SSA, Rehman W, Mehmood A, Idrees S, Kumar N. Prevalence of post-vaccine side effects among COVID-19 immunized community of Southern Pakistan. Plos One. 2023; 18(5): e0285736.
DOI: https://doi.org/10.1371/journal.pone.0285736
Daniel WW, Cross CL. Determination of sample size for estimating proportions. Biostatistics A foundation for analysis in the health sciences. 1999; 8: 189-90.
Hatmal MM, Al-Hatamleh MA, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, et al. Side effects and perceptions following COVID-19 vaccination in Jordan: A randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines. 2021; 9(6): 556.
DOI: https://doi.org/10.3390/vaccines9060556
Remmel A. COVID vaccines and safety: What the research says. Nature. 2021; 590(7847): 538-40.
DOI: https://doi.org/10.1038/d41586-021-00290-x
Anvari E, Talepoor AG, Vakili ME, Karimi N, Ataollahi M, Najafi G, et al. Comparison of the antibody responses following vaccination with Astra Zeneca and Sinopharm. Iran J Immunol. 2022; 19(3): 321.
DOI: https://doi.org/10.22034/iji.2022.94298.2300
Syed SSM, Ranjha AA, Ghazanfer S, Sultan HO, Sattar A, Miran SM, Hussain M. Prevalence and predictors for adverse effects of Sinopharm and Sinovac COVID-19 Vaccines. Professional Med J. 2024. 2022; 29(11): 1701-7.
DOI: https://doi.org/10.29309/TPMJ/2022.29.11.7116
Haider T, Abidi S, Fatima M, et al. (April 26, 2023) The Prevalence of side effects of Sinopharm COVID-19 vaccine: An experience from Pakistan. Cureus. 2023 Apr 26; 15(4): e38180. DOI: https://doi.org/10.7759/cureus.38180
Al Kaabi N, Oulhaj A, Ganesan S, Al Hosani FI, Najim O, Ibrahim H, et al. Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates. Nat Commun. 2022; 13(1): 3215.
DOI: https://doi.org/10.1038/s41467-022-30835-1
Elgendy MO, El-Gendy AO, Alzarea AI, Mahmoud S, Alqahtani SS, Fahmy AM, et al. SARS-CoV-2 post vaccinated adverse effects and efficacy in the Egyptian Population. Vaccines. 2021; 10(1): 18.
DOI: https://doi.org/10.3390/vaccines10010018
Nurzak AN, Iqbal M, Yunus A, Wahyuni DF. The evaluation of adverse effects of Sinovac® COVID-19 vaccine after receiving the first dose–maros health center. J Pharm Negat Results. 2022: 13(1): 78-83.
DOI: https://doi.org/10.47750/pnr.2022.13.S01.10
Yilmaz S, Çetin P, Khorshid L, Bayraktar D. Comparison of adverse effects of BioNTech mRNA and Sinovac vaccines in adults in Turkey. İKÇÜSBFD. 2023; 8(2): 395-400.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sarah Mansoor, Muhammad Hashim Nawaz, hira butt, Ayesha Chheena, Amina Zahid, Maham Nasir
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
